New patent for Benuvia drug SYNDROS

   March 10, 2022    Comments Off on New patent for Benuvia drug SYNDROS    Posted in: Patent Added

Annual Drug Patent Expirations for SYNDROS Syndros is a drug marketed by Benuvia and is included in one NDA. There are three patents protecting this drug and two Paragraph IV…

The post New patent for Benuvia drug SYNDROS appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog